|
Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1 Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1 conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1 Clinical research trials and Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1 healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1. Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1 Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1 clinical trial. Participants typically obtain the most effective healthcare available for their Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1 condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1  Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1
Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1
For Condition: Cocaine-Related Disorders,Drug Administration Schedule
Status: No longer recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) , University of Texas
Synopsis: To assess the efficacy and safety of 3 wide range doses of ondansetron to reduce cocaine use in subjects with cocaine dependence.
Details: Double-blind, placebo-controlled, 4-parallel group design to assess the efficacy and safety of 3 wide range doses of ondansetron to reduce cocaine use in subjects with cocaine dependence and to determine the optimal dose of ondansetron.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Male/Female, at least 18 yrs of age; DSM-4 diagnosis of cocaine dependence; seeking Treatment for cocaine dependence; have ability to understand, having understood and provide written consent; females of child bearing potential that use accepted method of birth control Exclusion Criteria: Additional criteria available during screening at the site.
Total Enrollment: 60
Location and Contact Information:
Overall Study Official:
JohnRoache, Principal Investigator, University of Texas
University of Texas Hlth Sci Ctr San Ant
San Antonio, Texas, 78284 7828
United States
Additional Information:
Study ID Numbers: NIDA-CTO-0005-1;
Study Start Date: May 2001
Record last reviewed: August 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00033085
Other Drug Administration Schedule Studies:
1. Naltrexone in Treatment of Cocaine Dependence - 5
2. Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
3. Development of Human Laboratory Study Model of Cocaine Relapse Prevention - 1
4. Efficacy of Nefazodone in Cocaine Dependent Subjects - 4
5. New Approaches to Cocaine Abuse Medications (A) - 6
Related Studies:
Other Drug Administration Schedule Clinical Trials
Other Texas Clinical Trials
Other San Antonio Clinical Trials
Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence - 1
|
|
|
|
|
|
|
|
